ASH
LIVE

Serial Number

87977301

Owner

American Society of Hematology, Inc.

Attorney

Christopher D. Casavale

First Use Date

Nov 15, 1996

Filing Date

Jul 28, 2017

Add to watchlist:

No watchlists yet
View on USPTO

ASH Trademark

Serial Number: 87977301 • Registration: 5570785

ASH is a trademark filed by American Society of Hematology, Inc. on July 28, 2017. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

American Society of Hematology, Inc. (30 trademarks)

Washington, DC 20036

Entity Type: 54

Trademark Details

Filing Date

July 28, 2017

Registration Date

September 25, 2018

First Use Anywhere

November 15, 1996

First Use in Commerce

February 1, 1991

Published for Opposition

July 10, 2018

Goods & Services

Educational services, namely, conducting seminars, non-downloadable webinars, meetings and lectures in the field of hematology; Educational services, namely, conducting classes and seminars in the field of hematology relating to current practice tools, clinical support, teaching cases, and continuing medical education (CME); Educational services, namely, providing incentives to hematologists to demonstrate excellence in the field of hematology through the issuance of awards; Providing a website featuring resources, namely, providing non-downloadable webinars, non-downloadable publications in the nature of articles, photographs and illustrations, and non-downloadable videos, all in the field of hematology; Providing recognition and incentives by the way of awards to demonstrate excellence in the field of hematology

Downloadable electronic publications in the nature of journals, magazines, and newsletters in the field of medicine and hematology; Downloadable mobile application featuring journals, magazines, and newsletters in the field of medicine and hematology; Electronic downloadable publications in the nature of journals, magazines, and newsletters in the field of medicine and hematology; Downloadable podcasts in the field of medicine and hematology

Publications in the nature of journals, magazines, and newsletters in the field of medicine and hematology

Financial services, namely, funding research awards and grants in the field of hematology; Charitable fundraising to support research, clinical care, education, training, and advocacy in the field of hematology; Charitable fundraising services in the field of hematology; Charitable fundraising services dedicated to curing blood diseases through financial support of research, career development, and quality care and education programs in the field of hematology

Public advocacy to promote awareness of the interests of scientists and clinicians working in the field of hematology; Association and membership services, namely, promoting research, clinical care, education, training, and advocacy interests of hematologists; Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of hematology research; promoting the exchange of information and resources within medical communities to achieve advances in the field of training and clinical care related to blood diseases; Administration and management of research grants; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of hematology; Maintaining a registry, namely, providing an on-line computer database of patients and patient medical information used for, among other purposes, research and publication

Platform as a service (PAAS) featuring online computer software platforms used for training in the field of hematology relating to current practice tools and clinical support, and used for administering self-assessment tests in the field of hematology; Developing quality control standards in the field of clinical guidelines, namely, development of medical and scientific research guidelines for clinical laboratory and healthcare testing in the field of hematology

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Apr 10, 2024 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 10, 2024 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 10, 2024 APRE
TEAS SECTION 8 & 15 RECEIVED
Oct 12, 2023 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 25, 2023 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 24, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 24, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 24, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 24, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 24, 2020 COAR
REGISTERED-PRINCIPAL REGISTER
Sep 25, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 10, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jul 10, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 20, 2018 NONP
POST PUBLICATION AMENDMENT - ENTERED
Jun 5, 2018 CHPB
WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
Jun 5, 2018 ISPO
ASSIGNED TO PETITION STAFF
Jun 1, 2018 APET
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 22, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 22, 2018 PUBO
TEAS POST PUBLICATION AMENDMENT RECEIVED
May 11, 2018 EPPA
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 2, 2018 NONP
ASSIGNED TO LIE
Apr 17, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 10, 2018 CNSA
DIVISIONAL PROCESSING COMPLETE
Apr 10, 2018 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 9, 2018 AITU
DIVISIONAL REQUEST RECEIVED
Mar 26, 2018 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Mar 26, 2018 ERTD
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 30, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jan 30, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jan 30, 2018 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 29, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 29, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 29, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 31, 2017 GNRN
NON-FINAL ACTION E-MAILED
Oct 31, 2017 GNRT
NON-FINAL ACTION WRITTEN
Oct 31, 2017 CNRT
ASSIGNED TO EXAMINER
Oct 30, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 2, 2017 NWOS
NEW APPLICATION ENTERED
Aug 1, 2017 NWAP